Michael Klayko insider trades: Allscripts Healthcare Solutions (MDRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 8, 2021 | MDRX | ↓ Sell | 28,000 | $18.03 | $505K | Direct | Jun 9, 2021 (1d) |
| Jun 4, 2021 | MDRX | ↓ Sell | 113,000 | $18.00 | $2.0M | Direct | Jun 4, 2021 (0d) |
| May 8, 2020 | CONE | ↓ Sell | 5,515 | $73.60 | $406K | Direct | May 8, 2020 (0d) |
| Mar 11, 2019 | CONE | ↑ Buy | 1,955 | $51.10 | $100K | Direct | Mar 11, 2019 (0d) |
| Dec 3, 2015 | PMCS | ↓ Sell | 44,701 | $11.91 | $532K | Direct | Dec 7, 2015 (4d) |
| Feb 4, 2015 | PMCS | ↓ Sell | 37,469 | $9.05 | $339K | Direct | Feb 6, 2015 (2d) |
| Feb 3, 2015 | PMCS | ↓ Sell | 153,566 | $8.97 | $1.4M | Direct | Feb 5, 2015 (2d) |
| Nov 11, 2014 | MDRX | ↑ Buy | 5,000 | $11.26 | $56K | Direct | Nov 12, 2014 (1d) |
| Aug 18, 2014 | MDRX | ↑ Buy | 3,500 | $14.41 | $50K | Direct | Aug 19, 2014 (1d) |
| Jun 13, 2014 | MDRX | ↑ Buy | 4,000 | $12.52 | $50K | Direct | Jun 14, 2018 (1462d) |
| Aug 15, 2013 | MDRX | ↑ Buy | 10,000 | $14.80 | $148K | Direct | Aug 19, 2013 (4d) |
| Aug 15, 2013 | PMCS | ↑ Buy | 15,000 | $6.26 | $94K | Direct | Aug 16, 2013 (1d) |
| Dec 28, 2012 | BRCD | ↓ Sell | 10,417 | $5.27 | $55K | Direct | Jan 2, 2013 (5d) |
| Dec 20, 2012 | BRCD | ↓ Sell | 1,082,207 | $5.46 | $5.9M | Direct | Dec 20, 2012 (0d) |
| Dec 20, 2012 | BRCD | ↓ Sell | 750,000 | $5.60 | $4.2M | By Trust | Dec 20, 2012 (0d) |
| Jun 13, 2012 | BRCD | ↑ Buy | 60,000 | $4.50 | $270K | By Trust | Jun 14, 2012 (1d) |
| Jun 5, 2012 | BRCD | ↑ Buy | 50,000 | $4.39 | $220K | By Trust | Jun 5, 2012 (0d) |
| Jun 28, 2011 | BRCD | ↓ Sell | 133,453 | $6.22 | $830K | Direct | Jun 30, 2011 (2d) |
| May 27, 2011 | BRCD | ↓ Sell | 50,000 | $6.57 | $329K | By Trust | Jun 1, 2011 (5d) |
| Dec 15, 2010 | BRCD | ↓ Sell | 50,000 | $5.31 | $266K | Direct | Dec 17, 2010 (2d) |
| Jun 4, 2010 | BRCD | ↑ Buy | 20,000 | $5.38 | $108K | Direct | Jun 4, 2010 (0d) |
| Jun 1, 2010 | BRCD | ↑ Buy | 10,000 | $5.39 | $54K | By Trust | Jun 1, 2010 (0d) |
| May 24, 2010 | BRCD | ↑ Buy | 10,000 | $5.34 | $53K | By Trust | May 24, 2010 (0d) |
| Nov 27, 2006 | BRCD | ↓ Sell | 1,079,943 | $8.97 | $9.7M | Direct | Nov 29, 2006 (2d) |
| Nov 27, 2006 | BRCD | ↓ Sell | 546,876 | $8.97 | $4.9M | By Partnership | Nov 29, 2006 (2d) |
| Nov 27, 2006 | BRCD | ↓ Sell | 53,124 | $8.97 | $477K | By Trust | Nov 29, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael Klayko's insider trades
Michael Klayko is a director at Allscripts Healthcare Solutions (MDRX). Since Nov 27, 2006, Michael has reported 11 open-market purchases worth $1.2M and 15 sales worth $31.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (34 filings), option exercises (15 filings), shares withheld for taxes (9 filings), other transactions (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.